Lobby Skips Australia's Election

SYDNEY—Scientific issues played virtually no role in Australia's federal election earlier this month, dashing scientists' hopes that the campaign would focus public attention on policy and funding questions and raising doubts about the effectiveness of the country's new science lobby. The formation last year of the Federation of Australian Scientific and Technological Societies (FASTS) had raised expectations that scientists' voices would be heard when the political dice were next thrown.

Written byPeter Pockley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The formation last year of the Federation of Australian Scientific and Technological Societies (FASTS) had raised expectations that scientists' voices would be heard when the political dice were next thrown. But FASTS, like most of the Australian electorate, was caught unprepared when Prime Minister Bob Hawke scheduled polling for July 11, and it did not mount a campaign.

Hawke, whose Labor government was returned to office in the election, had assured the nation that his government would serve out its full three-year term, which expires next year. But he later called for the election this month to capitalize on a major rift in the opposition coalition of Liberal and National parties.

David Widdup, executive director of FASTS, said his group had no time before the election to form a position that reflected the views of its 68 member societies. It apparently made no attempt to influence the election debate, either ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies